عرض: 25 50 75 100 النتائج

نتائج البحث: 5 من أصل 5

التغيرات الكيما حيوية في مصل الدم لتراكيز الهيبسيدين والانترلوكين - 6 نسبة لحالة الحديد قبل وبعد العلاج الكيميائي عند المرضى البالغين المصابين بسرطان الدم النيقاني الحاد == Biochemical Changes In Hepcidin And IL - 6 Concentrations Relative To Iron Status In Patients With Acute Myeloid Leukemia Before And After Treatment

اسم المؤلف: هبة عمار محمد
اسم المشرف: ختام عبد الوهاب علي | علاء فاضل علوان
الموضوع العام: الطب
السنة: 2015
الدرجة: ماجستير
اللغة: الانكليزية
مكان الجامعة: بغداد
الصفحات الاولى:
المستخلص: هدف الدراسة : لتعيين العلاقة بين هرمون الهبيسيدين (hepcidin) (الهرمون المنظم لتوازن الحديد في الجسم والانترلوكين - 6 ( (interlukin - 6و علاقتها ببعض المتغيرات الكيميائية الحياتية عند المرضى المصابين بابيضاض الدم النيقاني الحاد ((AML قبل وبعد اكمال الجرعة الك | Acute myeloid leukemia (AML) is a clonal, malignant disease of hematopoietic tissues characterized by the accumulation of abnormal blast cells, especially in bone marrow, and impaired production of normal blood cells. The statistics show that this disease in men is more prevalent than women and this type of leukemia is increasing with age. Objectives : To assess biochemical changes related to iron status in acute myeloid leukemia pre and post course of chemotherapy and evaluate a relationship between serum hepcidin and IL - 6 in patients with acute myeloid leukemia pre and post chemotherapy and compare their levels to controls and their contribution on the pathogenesis of AML.Patients, Materials and Methods : The present study conducted at the National Center of Hematology and Baghdad Teaching Hospital in the Medical City from February 2014 to June 2014.The study included Fifty - eight (58) patients (30 male and 28 female) diagnosed with acute myeloid leukemia the age of patients range (15 - 65 years). Forty three (43)patients continued the study (24 male and 19 female) divided into two groups : Group (1) Patients with AML before starting chemotherapy. Group (2) the patients after 4 weeks of chemotherapy. Patient's treatment was done according to international protocol used in acute myeloid leukemia and called (3+7) where Doxorubicin was given from the first day to third day and Cyatrabine (Ara - C) was given from the first day to seventh day.Evaluationwas done on day (28) from starting chemotherapy to assess response of patients through bone marrow aspiration.All patients were subjected to complete history and physical examination. Diagnosis of AML patients was established by complete blood count and blood film, bone morrow aspiration and biopsy, hepcidin, interlukine - 6, C - reactive protein, ferritin, iron, total iron binding capacity, alkaline phosphstase, direct bilirubin were done for all patients.Forty - three (43) healthy subjects (24 male and 19 female) were enrolled in the study mainly from medical staff and their families. They were age and sex matched to patients group and considered as controls as ( Group 3).Results : • Serum hipcidin levels were significantly higher in(AML)patients (Group 2) compared to newly diagnosed(Group 1) and to healthy subjects ( P<0.0001).• Serum (IL - 6) levels were higher but not significant in(Group 1) compared to (Group 2) and significantly with healthy controls(P<0.214 and P<0.0001 respectively).• A significant increase in mean of serum ferritin levels were observed in (Group 2) compared to newly diagnosed patients (Group 1)(P<0.002) and the levels were significantly higher in newly diagnosed group compared to healthy controls (P<0.015).• Patients with (AML) during remission show significant decrease in levels of iron compared to newly diagnosed group(P<0.0001),while levels in healthy controls was higher values than both (Group 2) and (Group 1) (P<0.0001).• Total iron binding capacity (TIBC ) levels showed a significant decrease in (Group 2) after treatment compared to (Group 1) before treatment(P<0.0001) but the levels were significantly higher in healthy controls compared to (Group 1) and (Group 2) (P<0.0001).• Mean serum ALP levels showed highly increase in (Group 2) patients when compared to patients before treatment (Group 1)( P<0.0001), but the difference is not significantly higher between the newly diagnosis and controls (P<0.687).• A significant increase in mean serum direct bilirubin levels were observed in (Group 2) patients when compared to (Group 1) and healthy controls(P<0.0001).• Regarded to CRP levels in AML patients before and after treatment, the CRP levels increased in AML patients after treatment than newly diagnosed AML patients.Conclusions : Hepcidin and Interlukin - 6 may be used asprognostic for acute myeloid leukemia and also can play an important role in pathogenesis of AML.

تقييم نسبة الاديبونيكتين والانترلوكين - 6 واضداد البروتين الستروليني في مصل الدم وتركيب الجسم مع الكثافة الكتلوية للعظم لدى المرضى المصابين بالفصال العظمي العقدي == Evaluation Of Serum Adiponectin , Interleukin - 6 , Anti - Cyclic Citrulinated Peptide And Body Mass Index With Bone Mineral Density In Nodal Osteoarthritis Patients

اسم المؤلف: مصطفى سالم خلف
اسم المشرف: عدنان فاضل النجار | عباس طعمة جودة الخزاعي
الموضوع العام: الطب
السنة: 2015
الدرجة: ماجستير
اللغة: الانكليزية
مكان الجامعة: بغداد
الصفحات الاولى:
المستخلص: الفصا العظمي العقدي هو واحد من انواع التهاب المفاصل الموضعي. هو مرض المفصل التنكسي او الانحلالي, ويشمل الغضروف المفصلي والعظم تحت الغضروف, وهو يعتبر نوع من انواع امراض المناعة الذاتية. السبب الرئيسي للفصال العظمي العقدي غير معروف لكن هناك اسباب متنوعة مثل | Nodal osteoarthritis (NOA) is one type of the localised osteoarthritis that mostly occurs with postmenopausal women. It is degenerative joint disease, including articular cartilage and subchondral bone, it consider type of autoimmune diseases. The main cause of NOA is unknown but there are variety of causes like hereditary and metabolic, may initiate processes leading to loss of cartilage. The cartilage loss process usually lead to induce the immune system to release many of immune factors like cytokines , these factors lead to generation of immune response and inflammation in the joint. The NOA mostly occurs with postmenopausal women. It affects the smaller joint. Over several years, firm knobbly swellings form on the finger joints. These are caused by osteophytes so lead to bony enlargement and are known as Heberden's nodes when they are at the end joints of fingers (distal interphalangeal joints) or Bouchard's nodes when they are at the mid - finger joints (proximal interphalangeal joints). Once the nodes are fully formed, and not necessarily painful, they do limit the movement of the fingers significantly. NOA leads to the formation of bunions, rendering them red or swollen. Some people notice these physical changes before they experience any pain, but in advance cases, many of Symptoms may include like joint pain, stiffness and sometimes an effusion. When bone surfaces become less well protected by cartilage, bone may be exposed and damaged. As a result of decreased movement secondary to pain, regional muscles may atrophy, and ligaments may become more lax.Many studies have been done about inflammatory and biochemical markers in NOA and they found conflicting results. Objective1 - To evaluate serum adiponectin , interleukin - 6 (IL - 6) , anti cyclic citrullinated peptide (ACCP) and bone mineral density (BMD) in NOA.2 - To asses the CRP , RF and ESR in NOA.3 - To asses effect of age , gender , effect of BMI , smoking habit and duration of disease in NOA.Material and Method This study performed during the period from November 2013 to February 2014. These subjects were selected from patients attending the Rheumatology & Rehabilitation Consultation Unit at Al - Yarmouk Teaching Hospital. Patients and controls with hypertension, diabetes mellitus, malignancy, chronic disease of kidney, liver and any patients taken drugs that might effect the results have been excluded from the study.The laboratory tests were done in Al - Yarmouk teaching hospital laboratories and the laboratory research unit in collage of medicine / department of medical biochemistry. Subjects80 subjects (60 patients & 20 healthy controls) were enrolled in this study : A. First group : Patients with Nodal Osteoarthritis (NOA), No. = 60 (female =49 & male =11), rang of age (40 - 88) years.B. Second group : Healthy control group who had no history or clinical evidence of NOA or any other chronic disease like hypertension, DM and other chronic disease that might effect on the study data, No. 20 (female = 15 & male =5 ), rang of age (48 - 82) years.The patients were diagnosed as NOA according to the 2013 American College of Rheumatology (ACR) criteria, also the patients were diagnosed as normal, osteopenia and osteoporosis according to the 2013 American College of Rheumatology (ACR) criteria by measured of BMD (T - score) Normal : T - score (more than or equal - 1), Osteopenia : T - score ( - 1.1 - - 2.5) and Osteoporosis : T - score (less than - 2.5). The patients BMI were measured and determined as Normal (18 - 24.9 kg/m2), Over weight (24.9 - 29.9 Kg/m2), Obese grade - I (29.9 - 34.9 kg/m2) and Obese grade - II (more than 34.9 kg/m2) according to WHO 2012.MethodsELISA technique was used for the determination of serum adiponectin, IL - 6 and ACCP. Measurement of serum uric acid was done by spectrophotometric instrument. qualitative serological tests were used for determination of the CRP and RF also ESR determination were done in hospital laboratory. The BMI was determined by WHO equation's (2012) (weight/ (length) 2), also the BMD was determined by DXA scan according to ACR limits.Results obtained were subjected to statistical analysis by using SPSS and Excel program.ResultsLevels of serum adiponectin, IL - 6, CRP, ESR and BMI were significantly increased in NOA patients most than healthy controls, also the BMD (T - score) significantly decreased in NOA patients than healthy controls. But the age, gender, serum ACCP and uric acid were not significantly changed in NOA patients compared with healthy controls. Study of age, gende , BMI and duration of disease, found that they did not effect any parameters studied in NOA patients, only serum ACCP level was found to be significantly increased in females than males. Serum adiponectin level and CRP were significantly increased more in osteoporosis than osteopenia and normal. CRP was significantly increased in smoker than non smoker NOA patients.This study showed negative correlation between serum adiponectin and BMD, positive correlation between serum adiponectin and ESR, serum adiponctin and IL - 6 and IL - 6 and ESR in NOA patients. This study illustrated change in the status of the inflammatory markers like adiponectin, IL - 6 and other parameters in NOA disease. It illustrated effect of some of the factors like age, gender, BMI, BMD, smoking habit and duration of disease on development of NOA disease and on the status of the parameters studied. Also this study illustrated some correlation between the parameters in NOA patients.

المرضى المصابين بالمتلازمة الشريانية الحاد Vaspin and Omentin - 1 : تقييم مستويات == Evaluation Of Serum Vaspin And Omentin - 1 Levels In Patients With Acute Coronary Syndrome

اسم المؤلف: مشتاق عبد هنيدي الطائي
اسم المشرف: ولاء احمد الجدة | عباس ناجي الشريفي
الموضوع العام: الطب
السنة: 2015
الدرجة: ماجستير
اللغة: الانكليزية
مكان الجامعة: بغداد
الصفحات الاولى:
المستخلص: Acute coronary syndrome (ACS) is an insufficient supply of the myocardium with oxygenated blood in which atherosclerosis is an essential cause of myocardial ischemia. Adipokine biomarkers plays an essential role in the atherosclerosis and hence coronary artery disease. Serum Vaspin, Omentin - 1 and troponin I Fast are the biomarkers that believed to be independently associated with acute coronary syndrome.Objective : The study was carried out to evaluate : serum Vaspin,Omentin - 1 and Troponin I Fast in patients with acute coronary syndrome [ST - Elevation Myocardial Infarction(STEMI), Non - ST - segment Elevation Myocardial Infarction (NSTEMI),and Unstable Angina pectoris (UA)], that may help in guiding the diagnosis and treatment.Subjects, Materials and Methods : The study include a total (100) individuals; (75) patients with acute coronary syndrome (ACS) and (25) healthy control.A total number of 75 patients with acute coronary syndrome (ACS) (50 male ,25 female ) as : 25 patients with STEMI (22 male and 3 female) 25 patients NSTEMI(16 male and 9 female ) and 25 patients with unstable angina UA(12 male and13 female)were enrolled in this study all taken from Coronary Care Unit (CCU)at AL - Yarmouk Teaching Hospital.Each patient was clinically examined by the consultant cardiologist and the diagnosis was achieved by electrocardiograph (ECG), and cardiac enzyme levels.Venous blood sample (ten milliliters) was drawn from each patient and control after (10 - 12) hours overnight fasting, using a 10 ml disposable syringe between 9.00 and 11.00 A.M.The sample was divided into two portions one for testing Hb concentration and the other part was centrifuged to obtain serum, to be used for measuring the following variables : serum vaspin, serum omentin - 1 and Troponin I Fast, total cholesterol, triglyceride, High density lipoprotein cholesterol and low - density lipoprotein cholesterol, fasting blood sugar, serum creatinine and uric acid.Body mass index was calculated according to the following equation : BMI=weight/height2, also blood pressure was measured.Results : Serum vaspin and omentin - 1 levels were significantly lower in patients groups in comparison with control group, while serum Troponin I fast, total cholesterol, and low density lipoprotein cholesterol levels were significantly higher in patients with coronary artery disease than controls. Negatively significant correlation was found between serum vaspin and omentin - 1 with (BMI, total cholesterol and troponin I Fast).Conclusion : Serum Vaspin and Omentin - 1 levels were lower in acute coronary syndrome patients in comparison with control group, serum vaspin and omentin - 1 showed significant changes with the development and progression of acute coronary syndrome and would be valuable in the assessment of patients with acute coronary syndrome.Vaspin and Omentin - 1 may be used as a predictor of ACS.

دور الهرمون مثبت الكالسيوم (الاوستيوكالسين) والهرمون شبيه الانسولين IGF - 1 في مصل الدم على هشاشة العظام لدى المصابات بداء السكري بعد سن الياس == The Role Of Osteocalcin And Insulin Like Growth Factor 1 (IGF - 1) On Osteoporosis In Diabetic Postmenopausal Women

اسم المؤلف: حيدر رضا محمد سعيد
اسم المشرف: نهلة مجيد الصقال | عبد الكريم يحيى السامرائي
الموضوع العام: الطب
السنة: 2015
الدرجة: ماجستير
اللغة: الانكليزية
مكان الجامعة: بغداد
الصفحات الاولى:
المستخلص: Osteoporosis is a systemic disease of the skeleton that characterized by low bone mass and alteration in micro - architecture of bone tissue, which leads to an increase in brittleness with the ensuing predisposition of bone fracture. Global statistics show that women are more exposed to this disease than men and in particular at menopause. Like osteoporosis, type 2 diabetes mellitus (T2DM) is also greatly related to aging populations, and causes substantial morbidity and in some cases mortality. Diabetes mellitus could affect skeletal system and bone metabolism through multiple pathways and it has been considered as a major risk factor of osteoporosis.Objective : The aim of the study is to evaluate the usefulness of osteocalcin (OC), insulin - like growth factor I (IGF - 1) and bone mineral density (BMD) in postmenopausal women with type2 diabetes mellitus with or without osteoporosis and to compare the results of them with that of healthy control, in addition on studying role in the pathochemistry of osteoporosis and their validation as biomarkers of osteoporosis.Subjects & Methods : The study was performed during December 2013 to April 2014. Subjects were selected from outpatients attended National Diabetic Center (NDC)/ AL - Mustansiriyhiah University.Eighty - six (86) postmenopausal women aging (50 - 72) were included in this study. Subjects were divided into three group (I) included (25) healthy postmenopausal women without osteoporosis and diabetes mellitus (controls), Group (II) included (30) diabetic postmenopausal women without osteoporosis, Group (III) included (31) diabetic postmenopausal women with osteoporosis.Osteoporosis was diagnosed by measuring bone mineral density (BMD) by Dual energy X - ray absorptiometry (DXA). Also the levels of Fasting blood glucose (FBG), Calcium and phosphorus alkaline phosphatase (ALP) by spectrophotometer were measured in addition to measuring HbA1c level by NycoCard device using boronate assay affinity. While serum osteocalcin was measured using (ELISA) technique and IGF - 1 was measured using immunoradiometric assay. patients with malignant diseases, hyperthyroidism, hyperparathyroidism, osteomalacia, renal and hepatic diseases were excluded in addition to patients with chronic treatment with antiacids, estrogen, adrenal or anabolic steroids, anticonvulsants and anti - coagulants. Meanwhile, we ensured that all patients are not alcohol addiction and not smokers (passive & active).ResultsBone mineral density (BMD) was lower significantly in diabetic type II postmenopausal women with osteoporosis compared to diabetic type II postmenopausal women without osteoporosis and control group (0.68±0.04 g/cm2) , ( 0.87±0.03 g/cm2) , (0.89 ± 0.04 g/cm2), (P<0.001) respectively.The mean serum OC was lower significantly in diabetic type II postmenopausal women with osteoporosis group compared to diabetic type II postmenopausal women without osteoporosis group and control group (22.3±5.92 ng/ml), (27.2±5.96ng/ml), (27.3 ±3.49ng/ml) (P<0.001) respectively. Also the mean serum IGF - 1 was lower significantly in diabetic type II postmenopausal women with osteoporosis group compared to diabetic type II postmenopausal women without osteoporosis group and control group (46.6±8.41ng/ml), (65±8.48ng/ml), (88.2 ± 9.91ng/ml) (P<0.001) respectively.The mean of Fasting Blood Glucose was higher significantly in diabetic type II postmenopausal women with osteoporosis group compared to diabetic type II postmenopausal women without osteoporosis group, and control group (204.4±15.29 mg/dl), (187.2±13.45 mg/dl) , (93 ± 7.79 mg/dl) (P<0.001) respectively.The mean HbA1c was higher significantly in diabetic type II postmenopausal women with osteoporosis group compared to diabetic type II postmenopausal women without osteoporosis group, and control group (8±0.5), (7.5±0.53), (5.2 ± 0.33), (P<0.001) respectively.Also results showed no significant change in levels of calcium, phosphorus and alkaline phosphatase in the serum of diabetic type II postmenopausal women with osteoporosis group, compared to diabetic type II postmenopausal women without osteoporosis group and control group.There was a significant positively correlation between BMD with serum osteocalcin (r=0.43, P<0.001) and a strong positively significant correlation between BMD with serum IGF - 1(r=0.706, P<0.001). Also there was a significant negative correlation between BMD with HbA1c ( r= - 0.339, P=0.001), FBG(r= - 0.457, P<0.005) and Age (r= - 0.466, P<0.001).Also there was a positively significant correlation between serum osteocalcin with IGF - 1 (r= 0.34,p=0.007) and serum osteocalcin with BMD (r=0.43, P<0.001).Simultaneously there was a positively significant correlation between serum IGF - 1 and ostocalcin (r=0.34,p=0.007) and a positively significant correlation between serum IGF - 1 and BMD( (r=0.706, P<0.001). Also there was a negatively significant correlation between serum IGF - 1 with HbA1c (r= - 0.332,p=0.009), FBG(r= - 0.345,p=0.005) and Age (r= - 0.496, P<0.001).Conculsion Assessing the circulating levels of osteocalin and IGF - 1 may provide very useful information to diagnose or predict osteoporosis in Type 2 diabetic postmenopausal women.

دور ال Inhibin - B,FSH وهرمون التستيستيرون في الذكور المصابين بالعقم == Role Of INHIBIN - B Hormone, Follicular Stimulating Hormone, And Testosterone In Infertile Men

اسم المؤلف: احمد عبد الرحيم ابراهيم ضاحي
اسم المشرف: شذى الخطيب | صباح مهدي حسين
الموضوع العام: الطب
السنة: 2015
الدرجة: ماجستير
اللغة: الانكليزية
مكان الجامعة: بغداد
الصفحات الاولى:
المستخلص: تقييم مستوى هرمون الانهبين.ب. وهرمون المحفز للجريب والتيستوستيرون واللوتيني وهرمون الحليب والاستراديول في مصل والسائل المنوي للاشخاص العقيمين ومعرفة ايهم فائدة اكثر للتشخيص المبكر للعقم بعد مقارنة النتائج مع الاشخاص الاصحاء.المكانوقد اجريت هذه الدراسة خ